Form 4: ATI Physical Therapy CEO Awarded Stock Options

Sentiment:

SEC Form 4 Filing


Sharon Vitti, CEO of ATI Physical Therapy, received stock options with varying exercise prices and vesting schedules.

Summary

  • On August 20, 2024, Sharon Vitti, the CEO of ATI Physical Therapy, was granted stock options.
  • The options have exercise prices of $10, $12.5, $25, and $50.
  • A total of 1,176,710 options were granted, exercisable into Class A Common Stock.
  • The options expire on August 20, 2034, except for 19,126 options which expire on May 12, 2032.
  • Vesting occurs in three equal installments on April 1, 2025, April 1, 2026, and April 1, 2027, contingent upon continued service.
  • 19,126 options vest on the first three anniversaries of May 12, 2022.
  • The filing also reflects a prior reverse stock split of 1-for-50 that occurred on June 14, 2023.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices. The stock options incentivize the CEO, which is generally viewed favorably.

Positives

  • The granting of stock options to the CEO aligns her interests with those of the shareholders.
  • The vesting schedule encourages long-term commitment from the CEO.

Industry Context

Stock option grants are a common practice in the healthcare industry to incentivize executives and align their interests with shareholders.

Comparison to Industry Standards

  • Stock option grants are a typical component of executive compensation packages in publicly traded companies, including those in the physical therapy and healthcare services sectors.
  • The vesting schedules and exercise prices are generally in line with industry standards for incentivizing long-term performance.
  • Comparable companies such as U.S. Physical Therapy, Inc. (USPH) and Select Medical Holdings Corporation (SEM) also utilize stock options as part of their executive compensation plans.

Stakeholder Impact

  • Shareholders may view the stock option grant positively as it aligns the CEO's interests with the company's long-term success.
  • Employees may be motivated by the potential for improved company performance driven by incentivized leadership.

Key Dates

DateDescription
May 12, 2022Grant date of 19,126 stock options with an exercise price of $78.
June 14, 2023Date of the 1-for-50 reverse stock split.
April 1, 2025First vesting date for one-third of the newly granted stock options.
April 1, 2026Second vesting date for one-third of the newly granted stock options.
April 1, 2027Final vesting date for one-third of the newly granted stock options.
August 20, 2024Date of the stock option grant to Sharon Vitti.
August 22, 2024Date of the form filing.

Keywords

stock options, ATI Physical Therapy, Sharon Vitti, CEO, Form 4, insider trading, beneficial ownership, ATIP

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.